CHA2DS2-VASc Score
Cross-source consensus on CHA2DS2-VASc Score from 1 sources and 5 claims.
1 sources · 5 claims
How it works
Comparisons
Highlighted claims
- Baseline stroke risk was stratified using the CHA2DS2-VASc score distribution from STROKE AF, where the median score was 5. — Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in large- or small-vessel disease ischaemic stroke in the USA
- CHA2DS2-VASc score was the strongest modifier of ICM cost-effectiveness. — Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in large- or small-vessel disease ischaemic stroke in the USA
- ICM was economically dominant for patients with CHA2DS2-VASc scores of 7 to 8. — Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in large- or small-vessel disease ischaemic stroke in the USA
- ICM was not cost-effective for patients with CHA2DS2-VASc scores of 2 to 3. — Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in large- or small-vessel disease ischaemic stroke in the USA
- ICM was cost-effective for patients with CHA2DS2-VASc scores of 4 to 6. — Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in large- or small-vessel disease ischaemic stroke in the USA